|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000105605 |
Summary for CACNG7 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000105605 | Gene symbol | CACNG7 |
| Gene name | calcium voltage-gated channel auxiliary subunit gamma 7 | |
| HGNC | 13626 | |
| Entrez ID | 59284 | |
| Gene type | protein_coding | |
| Synonyms | CACNG7| | |
| UniProtAcc | P62955 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000105605 | CACNG7 | DB00153 | Ergocalciferol | SmallMoleculeDrug |
| ENSG00000105605 | CACNG7 | DB00228 | Enflurane | SmallMoleculeDrug |
| ENSG00000105605 | CACNG7 | DB00421 | Spironolactone | SmallMoleculeDrug |
| ENSG00000105605 | CACNG7 | DB11148 | Butamben | SmallMoleculeDrug |
| ENSG00000105605 | CACNG7 | DB13746 | Bioallethrin | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CACNG7 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for CACNG7 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CACNG7 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| MESO | cg21093192 | chr19:53909739 | CGI:chr19:53909456-53909833 | promoter,gene body | 6.07e-02 | 1.73e-01 | -2.27e+00 | 2.32e-02 | 4.08e-02 | -1.13e-01 |
| MESO | cg12570712 | chr19:53909631 | CGI:chr19:53909456-53909833 | promoter,gene body | 1.26e-01 | 2.49e-01 | -2.67e+00 | 7.61e-03 | 2.41e-02 | -1.23e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 1.45e-01 | 2.63e-02 | 5.45e+00 | 5.16e-08 | 2.84e-07 | 1.18e-01 |
| KIRC | cg12570712 | chr19:53909631 | CGI:chr19:53909456-53909833 | promoter,gene body | 1.98e-01 | 6.58e-02 | 6.48e+00 | 9.24e-11 | 2.53e-09 | 1.32e-01 |
| HNSC | cg05344295 | chr19:53908255 | CGI:chr19:53908122-53908714 | promoter | 2.70e-01 | 6.58e-02 | 2.97e+00 | 2.96e-03 | 4.56e-03 | 2.04e-01 |
| LUSC | cg21093192 | chr19:53909739 | CGI:chr19:53909456-53909833 | promoter,gene body | 3.04e-01 | 3.65e-02 | 3.87e+00 | 1.08e-04 | 7.20e-04 | 2.67e-01 |
| LUSC | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 1.96e-01 | 2.41e-02 | 3.38e+00 | 7.20e-04 | 2.09e-03 | 1.72e-01 |
| LUSC | cg14148055 | chr19:53908519 | CGI:chr19:53908122-53908714 | promoter | 1.54e-01 | 1.84e-02 | 3.89e+00 | 1.02e-04 | 7.03e-04 | 1.36e-01 |
| LUSC | cg12570712 | chr19:53909631 | CGI:chr19:53909456-53909833 | promoter,gene body | 2.73e-01 | 9.46e-02 | 3.02e+00 | 2.49e-03 | 4.89e-03 | 1.79e-01 |
| BLCA | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 3.20e-01 | 6.73e-02 | 3.57e+00 | 3.56e-04 | 1.02e-03 | 2.53e-01 |
| BLCA | cg14148055 | chr19:53908519 | CGI:chr19:53908122-53908714 | promoter | 2.72e-01 | 4.56e-02 | 3.40e+00 | 6.85e-04 | 1.69e-03 | 2.26e-01 |
| BLCA | cg12570712 | chr19:53909631 | CGI:chr19:53909456-53909833 | promoter,gene body | 3.19e-01 | 1.18e-01 | 3.01e+00 | 2.60e-03 | 4.83e-03 | 2.02e-01 |
| CHOL | cg21093192 | chr19:53909739 | CGI:chr19:53909456-53909833 | promoter,gene body | 3.09e-01 | 3.12e-02 | 2.43e+00 | 1.50e-02 | 2.65e-02 | 2.77e-01 |
| CHOL | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 3.03e-01 | 4.79e-02 | 2.21e+00 | 2.70e-02 | 3.50e-02 | 2.55e-01 |
| CHOL | cg14148055 | chr19:53908519 | CGI:chr19:53908122-53908714 | promoter | 3.76e-01 | 2.99e-02 | 2.73e+00 | 6.38e-03 | 1.82e-02 | 3.46e-01 |
| CHOL | cg12570712 | chr19:53909631 | CGI:chr19:53909456-53909833 | promoter,gene body | 3.97e-01 | 1.03e-01 | 2.14e+00 | 3.25e-02 | 3.87e-02 | 2.94e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg05344295 | chr19:53908255 | CGI:chr19:53908122-53908714 | promoter | 1.55e-01 | 4.19e-02 | 6.50e+00 | 8.15e-11 | 2.16e-10 | 1.13e-01 |
| BRCA | cg21093192 | chr19:53909739 | CGI:chr19:53909456-53909833 | promoter,gene body | 3.49e-01 | 4.24e-02 | 1.31e+01 | 4.35e-39 | 2.73e-37 | 3.07e-01 |
| BRCA | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 2.85e-01 | 4.38e-02 | 1.12e+01 | 4.09e-29 | 5.37e-28 | 2.41e-01 |
| BRCA | cg14148055 | chr19:53908519 | CGI:chr19:53908122-53908714 | promoter | 2.06e-01 | 2.28e-02 | 1.13e+01 | 1.91e-29 | 2.61e-28 | 1.83e-01 |
| BRCA | cg12570712 | chr19:53909631 | CGI:chr19:53909456-53909833 | promoter,gene body | 2.77e-01 | 1.03e-01 | 9.52e+00 | 1.79e-21 | 1.10e-20 | 1.74e-01 |
| LIHC | cg21093192 | chr19:53909739 | CGI:chr19:53909456-53909833 | promoter,gene body | 1.94e-01 | 3.35e-02 | 3.26e+00 | 1.13e-03 | 2.49e-03 | 1.61e-01 |
| LIHC | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 2.19e-01 | 3.29e-02 | 3.67e+00 | 2.43e-04 | 7.56e-04 | 1.86e-01 |
| LIHC | cg14148055 | chr19:53908519 | CGI:chr19:53908122-53908714 | promoter | 1.51e-01 | 2.68e-02 | 2.04e+00 | 4.15e-02 | 4.31e-02 | 1.24e-01 |
| KIRP | cg15680755 | chr19:53908414 | CGI:chr19:53908122-53908714 | promoter | 1.35e-01 | 2.78e-02 | 2.60e+00 | 9.43e-03 | 1.62e-02 | 1.07e-01 |
Top |
Exon skipping events with PSI in TCGA for CACNG7 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CACNG7 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CACNG7 |
TFs related to CACNG7.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
CACNG7 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CACNG7 |
RBPs related to ES in CACNG7.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
CACNG7 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000105605 | KCNQ1OT1,hsa-mir-142,CACNG7 | Male-specific ceRNA | TCGA-HNSC |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_311170 | chr19:53941469:53941615 | Frame-shift | rs11670358 | chr19:53501148:T:A | Distant upstream | -0.0222321679788507 | 0.018870833510381 | LGG | Male-baised sQTL |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| exon_skip_311170 | chr19:53941469:53941615 | cg25693289 | chr19:53869371 | Distant upstream | -0.0217346304801046 | 2.84702992195083e-05 | -0.4037291940616099 | 1.6556543389721833e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg11418112 | chr19:53869356 | Distant upstream | -0.0217674094679902 | 3.21234489764971e-05 | -0.4045129057960688 | 1.514805083119219e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg22938308 | chr19:53869673 | Distant upstream | -0.0217059830439846 | 3.44624740468145e-05 | -0.39775365556851416 | 3.2366333825401936e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg18844210 | chr19:53869364 | Distant upstream | -0.0216113617201389 | 4.65668574894127e-05 | -0.403316681436892 | 1.899809611920335e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg25791973 | chr19:53869554 | Distant upstream | -0.0215229583586185 | 5.56498052748704e-05 | -0.4065320479699862 | 1.2034023794493215e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg04053204 | chr19:53869696 | Distant upstream | -0.0215229583586185 | 5.56498052748704e-05 | -0.3832144554811131 | 1.5653701258820735e-09 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg23520075 | chr19:53868690 | Distant upstream | -0.0208284837557774 | 6.37117363854344e-05 | -0.3896446980184064 | 7.870186704149787e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg07454803 | chr19:53868741 | Distant upstream | -0.0204605961348842 | 7.80184079080222e-05 | -0.3808676306078665 | 2.0045053655759076e-09 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg12586594 | chr19:53869455 | Distant upstream | -0.0212462045012756 | 8.54037411681424e-05 | -0.40604659243547336 | 1.2720427757575197e-10 | Frame-shift | LGG |
| exon_skip_311170 | chr19:53941469:53941615 | cg27294816 | chr19:53869459 | Distant upstream | -0.0212462045012756 | 8.54037411681424e-05 | -0.4080625001341748 | 1.0097349395100829e-10 | Frame-shift | LGG |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CACNG7 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |